Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription 22.07.2024 2 AJR Am J Roentgenol 1 Am J Gastroenterol 3 Biochem Biophys Res Commun 2 BMC Cancer 2 BMC Gastroenterol 1 Br J Surg 3 Cancer 1 Dig Dis Sci 1 Endoscopy 2 Eur Radiol 1 Gastrointest Endosc 12 Hepatology 1 Indian J Gastroenterol 1 Int J Cancer 1 J Gastroenterol 1 J Gastroenterol Hepatol 1 J Hepatol 1 J Pediatr Surg 2 Oncogene 5 Semin Liver Dis 2 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DABIRI BE
   Editorial Comment: Ablation for Early-Stage Hepatocellular Carcinoma Results in Lower Costs Relative to Both Surgical Resection and Transplant.
   AJR Am J Roentgenol. 2024 Jul 17. doi: 10.2214/AJR.24.31657.
   PubMed        
   
   
2. CAO JJ, Shen L, Yoon L, Kamaya A, et al
   Differentiation of Hepatocellular Adenoma Subtypes and Focal Nodular Hyperplasia on Gadoxetate Disodium-Enhanced MRI: An Updated Diagnostic Algorithm.
   AJR Am J Roentgenol. 2024 Jul 17. doi: 10.2214/AJR.24.31628.
   PubMed        
   
   

   
   Am J Gastroenterol

3. TAPPER EB, Goldberg D, Parikh ND, Terrault NA, et al
   The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
   Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002953.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

4. CHEN Y, Zhang Y, Jin X, Hong S, et al
   Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease.
   Biochem Biophys Res Commun. 2024;726:150305.
   PubMed         Abstract available
   
   
5. YU T, Wang L, Cheng Y, Zhang Y, et al
   Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.
   Biochem Biophys Res Commun. 2024;726:150264.
   PubMed         Abstract available
   
   
6. GWON HJ, Chung YH, Lim DS, Cho W, et al
   Uvaol ameliorates lipid deposition in hyperlipidemic hepatocytes by suppressing protein-tyrosine phosphatase 1B/ER stress signaling.
   Biochem Biophys Res Commun. 2024;730:150387.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. CHENG Q, Ji W, Lv Z, Wang W, et al
   Comprehensive analysis of PHF5A as a potential prognostic biomarker and therapeutic target across cancers and in hepatocellular carcinoma.
   BMC Cancer. 2024;24:868.
   PubMed         Abstract available
   
   
8. KY TD, Loan NT, Thinh NT, Binh MT, et al
   Nonadherence to oral cancer chemotherapy in hepatocellular carcinoma: prevalence and predictive factors in Vietnam.
   BMC Cancer. 2024;24:841.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

9. ELHOSEENY MM, Abdulaziz BA, Mohamed MA, Elsharaby RM, et al
   Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study.
   BMC Gastroenterol. 2024;24:226.
   PubMed         Abstract available
   
   
10. SHI Y, Feng W, Cai J, Wang Z, et al
    Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study.
    BMC Gastroenterol. 2024;24:224.
    PubMed         Abstract available
    
    

    
    Br J Surg

11. BAHRI S, Brown L, Perin G, Balasubramanian SP, et al
    Comment on: Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae171.
    PubMed        
    
    

    
    Cancer

12. SPUNT SL, Xue W, Gao Z, Hayes Dixon A, et al
    Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.
    Cancer. 2024;130:2683-2693.
    PubMed         Abstract available
    
    
13. AWAD A, Pal K, Yevich S, Kuban JD, et al
    Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.
    Cancer. 2024;130:2703-2712.
    PubMed         Abstract available
    
    
14. VAN NOESEL MM
    Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver.
    Cancer. 2024;130:2582-2585.
    PubMed        
    
    

    
    Dig Dis Sci

15. STERN C, Ngo A, Villela-Nogueira C, Thabut D, et al
    A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases.
    Dig Dis Sci. 2024;69:2648-2654.
    PubMed         Abstract available
    
    

    
    Endoscopy

16. MARTINEZ-MORENO B, Martinez Martinez J, Herrera I, Guilabert L, et al
    Correlation of EUS-guided portal pressure gradient measurements with hepatic venous pressure gradient: a prospective study.
    Endoscopy. 2024 Jul 18. doi: 10.1055/a-2369-0759.
    PubMed         Abstract available
    
    

    
    Eur Radiol

17. POETTER-LANG S, Ambros R, Messner A, Kristic A, et al
    Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study.
    Eur Radiol. 2024;34:5215-5227.
    PubMed         Abstract available
    
    
18. GROSS M, Huber S, Arora S, Ze'evi T, et al
    Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomics.
    Eur Radiol. 2024;34:5056-5065.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

19. TEPOX-PADRON A, Mohamed R, Li S
    Coil migration into the pulmonary artery after gastric variceal EUS-guided coil embolization.
    Gastrointest Endosc. 2024;100:330-332.
    PubMed        
    
    

    
    Hepatology

20. BERENGUER J, Bellon JM, Banares R, Gonzalez-Garcia J, et al
    Reply: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.
    Hepatology. 2024 Jun 20. doi: 10.1097/HEP.0000000000000977.
    PubMed        
    
    
21. 
    Diagnosis and Management of Hepatocellular Carcinoma.
    Hepatology. 2024 Jul 17. doi: 10.1097/HEP.0000000000001010.
    PubMed        
    
    
22. CELSA C, Cabibbo G, Fulgenzi CAM, Battaglia S, et al
    Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
    Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001026.
    PubMed         Abstract available
    
    
23. JEONG JM, Choi SE, Shim YR, Kim HH, et al
    CX3CR1+ macrophages interact with hepatic stellate cells to promote hepatocellular carcinoma through CD8+ T cell suppression.
    Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001021.
    PubMed         Abstract available
    
    
24. HLADY RA, Robertson KD
    Epigenetic memory of environmental exposures as a mediator of liver disease.
    Hepatology. 2024;80:451-464.
    PubMed         Abstract available
    
    
25. YANG D, Tian T, Li X, Zhang B, et al
    ZNT1 and Zn 2+ control TLR4 and PD-L1 endocytosis in macrophages to improve chemotherapy efficacy against liver tumor.
    Hepatology. 2024;80:312-329.
    PubMed         Abstract available
    
    
26. WANG Q, Bu Q, Pan B, Yin Y, et al
    Letter to the Editor: Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury.
    Hepatology. 2024;80:E24-E25.
    PubMed        
    
    
27. JEPSEN P, West J, Kann AE, Kraglund F, et al
    Risk of alcohol-associated liver disease in the offspring of parents with alcohol-associated liver disease: A nationwide cohort study.
    Hepatology. 2024;80:418-427.
    PubMed         Abstract available
    
    
28. RAMAN KP, Patch D
    Tranexamic acid in variceal bleeding revisited.
    Hepatology. 2024;80:257-259.
    PubMed        
    
    
29. GARCIA-TSAO G, Kaplan DE
    Reply: Endoscopy for potential variceal bleeding within 12 hours-Not so fast!
    Hepatology. 2024;80:E36.
    PubMed        
    
    
30. 
    Hepatology Highlights.
    Hepatology. 2024;80:255-256.
    PubMed        
    
    
31. 
    August Hepatology Highlights.
    Hepatology. 2023;78:369-370.
    PubMed        
    
    

    
    Indian J Gastroenterol

32. ALEXANDER V, Chellaiya GK, Gnanadeepam S, David VG, et al
    On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange.
    Indian J Gastroenterol. 2024 Jul 13. doi: 10.1007/s12664-024-01585.
    PubMed         Abstract available
    
    

    
    Int J Cancer

33. VAZ J, Jepsen P, Stromberg U, Midlov P, et al
    Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35097.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

34. HAO Y, Hao Z, Zeng X, Lin Y, et al
    Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation.
    J Gastroenterol. 2024 Jul 19. doi: 10.1007/s00535-024-02134.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

35. CHU CS, Chen HP, Lin PH, Cheng CC, et al
    Interleukin-1 receptor 1 deficiency worsens hepatocellular carcinoma, while gemcitabine treatment alleviates the hepatocellular carcinoma-induced increase in intra-hepatic immune cells.
    J Gastroenterol Hepatol. 2024 Jul 15. doi: 10.1111/jgh.16674.
    PubMed         Abstract available
    
    

    
    J Hepatol

36. DI COLA S, D'Amico G, Merli M
    Reply to "Reevaluating Myosteatosis Criteria in Cirrhosis: Fluid and Gender Considerations ".
    J Hepatol. 2024 Jul 11:S0168-8278(24)02353-5. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    

    
    J Pediatr Surg

37. DAVENPORT M, Superina R
    Primary Liver Transplant in Biliary Atresia: The Case for and Against.
    J Pediatr Surg. 2024 Mar 14:S0022-3468(24)00156.
    PubMed         Abstract available
    
    

    
    Oncogene

38. ZHANG T, Zhao F, Hu Y, Wei J, et al
    Environmental monobutyl phthalate exposure promotes liver cancer via reprogrammed cholesterol metabolism and activation of the IRE1alpha-XBP1s pathway.
    Oncogene. 2024;43:2355-2370.
    PubMed         Abstract available
    
    
39. LI W, Guo Z, Zhou Z, Zhou Z, et al
    Distinguishing high-metastasis-potential circulating tumor cells through fluidic shear stress in a bloodstream-like microfluidic circulatory system.
    Oncogene. 2024;43:2295-2306.
    PubMed         Abstract available
    
    

    
    Semin Liver Dis

40. WERNER W, Kuzminskaya M, Lurje I, Tacke F, et al
    Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
    Semin Liver Dis. 2024;44:159-179.
    PubMed         Abstract available
    
    
41. FISCHER AM, Lechea N, Coxson HO
    This Is What Metabolic Dysfunction-Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol.
    Semin Liver Dis. 2024;44:226-238.
    PubMed         Abstract available
    
    
42. LI CC, Liu M, Lee HP, Wu W, et al
    Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives.
    Semin Liver Dis. 2024;44:133-146.
    PubMed         Abstract available
    
    
43. PHAM N, Benhammou JN
    Statins in Chronic Liver Disease: Review of the Literature and Future Role.
    Semin Liver Dis. 2024;44:191-208.
    PubMed         Abstract available
    
    
44. FUJIWARA N, Kimura G, Nakagawa H
    Emerging Roles of Spatial Transcriptomics in Liver Research.
    Semin Liver Dis. 2024;44:115-132.
    PubMed         Abstract available
    
    

    
    Transplant Proc

45. THULUVATH AJ, Kim M, Peipert J, Duarte-Rojo A, et al
    Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis.
    Transplant Proc. 2024 Jul 17:S0041-1345(24)00326.
    PubMed         Abstract available
    
    
46. WANG N, Zhu Z, Zheng H, Qi C, et al
    Diagnosis and Treatment of Hepatic Hematoma After Liver Transplantation in a Timely Manner.
    Transplant Proc. 2024 Jul 13:S0041-1345(24)00343.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.